Myoferlin silencing inhibits VEGFR2-mediated proliferation of metastatic clear cell renal cell carcinoma

Recently, ramucirumab, a drug that targets vascular endothelial growth factor receptor (VEGFR), was clinically approved; therefore, we evaluated VEGFR2 expression and its predictive roles in tumor progression in clear cell renal cell carcinoma (CCRCC). Since we do not have many options for treating...

Descripción completa

Detalles Bibliográficos
Autores principales: An, Hyo Jung, Song, Dae Hyun, Koh, Hyun Min, Kim, Yu-Min, Ko, Gyung Hyuck, Lee, Jeong-Hee, Lee, Jong Sil, Yang, Jung Wook, Kim, Min Hye, Seo, Deok Ha, Jang, Se Min, Kim, Dong Chul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718427/
https://www.ncbi.nlm.nih.gov/pubmed/31477752
http://dx.doi.org/10.1038/s41598-019-48968-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718427/
https://www.ncbi.nlm.nih.gov/pubmed/31477752
http://dx.doi.org/10.1038/s41598-019-48968-7

Ejemplares similares